JP2001525826A5 - - Google Patents

Download PDF

Info

Publication number
JP2001525826A5
JP2001525826A5 JP1998549602A JP54960298A JP2001525826A5 JP 2001525826 A5 JP2001525826 A5 JP 2001525826A5 JP 1998549602 A JP1998549602 A JP 1998549602A JP 54960298 A JP54960298 A JP 54960298A JP 2001525826 A5 JP2001525826 A5 JP 2001525826A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP1998549602A
Other languages
English (en)
Japanese (ja)
Other versions
JP2001525826A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US1998/010013 external-priority patent/WO1998051348A2/en
Publication of JP2001525826A publication Critical patent/JP2001525826A/ja
Publication of JP2001525826A5 publication Critical patent/JP2001525826A5/ja
Ceased legal-status Critical Current

Links

JP54960298A 1997-05-16 1998-05-18 持続放出性遅延型ゲル Ceased JP2001525826A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US85797397A 1997-05-16 1997-05-16
US08/857,973 1997-05-16
US91290297A 1997-08-15 1997-08-15
US08/912,902 1997-08-15
PCT/US1998/010013 WO1998051348A2 (en) 1997-05-16 1998-05-18 Sustained-release delayed gels

Publications (2)

Publication Number Publication Date
JP2001525826A JP2001525826A (ja) 2001-12-11
JP2001525826A5 true JP2001525826A5 (enExample) 2005-12-08

Family

ID=27127437

Family Applications (1)

Application Number Title Priority Date Filing Date
JP54960298A Ceased JP2001525826A (ja) 1997-05-16 1998-05-18 持続放出性遅延型ゲル

Country Status (18)

Country Link
EP (1) EP0981374B1 (enExample)
JP (1) JP2001525826A (enExample)
KR (1) KR20010012374A (enExample)
AU (1) AU7491898A (enExample)
BG (1) BG64860B1 (enExample)
BR (1) BR9809117A (enExample)
CA (1) CA2289196C (enExample)
CZ (1) CZ299180B6 (enExample)
DE (1) DE69838750T2 (enExample)
EA (1) EA199901013A1 (enExample)
ES (1) ES2294814T3 (enExample)
HU (1) HUP0003393A3 (enExample)
IL (1) IL132814A0 (enExample)
NO (1) NO995591D0 (enExample)
PL (1) PL199565B1 (enExample)
SK (1) SK286437B6 (enExample)
WO (1) WO1998051348A2 (enExample)
YU (1) YU58599A (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9572800B2 (en) 2012-11-08 2017-02-21 Clearside Biomedical, Inc. Methods and devices for the treatment of ocular diseases in human subjects

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003200609B2 (en) * 1998-05-18 2006-02-23 Amgen Inc. Biodegradable sustained-release alginate gels
US6432449B1 (en) * 1998-05-18 2002-08-13 Amgen Inc. Biodegradable sustained-release alginate gels
JP2000256216A (ja) * 1999-03-04 2000-09-19 Meiji Milk Prod Co Ltd ゲル組成物
US7582311B1 (en) 1999-10-15 2009-09-01 Genentech, Inc. Injection vehicle for polymer-based formulations
US7651703B2 (en) 1999-10-15 2010-01-26 Genentech, Inc. Injection vehicle for polymer-based formulations
CA2396431A1 (en) * 1999-11-29 2001-05-31 Advanced Research And Technology Institute, Inc. Sustained percutaneous delivery of a biologically active substance
FR2823119B1 (fr) * 2001-04-05 2004-02-20 Seppic Sa Adjuvant d'immunite contenant un cation metallique complexe et vaccin le contenant
KR20050071611A (ko) * 2002-10-25 2005-07-07 화이자 프로덕츠 인코포레이티드 현탁액 형태의 아릴헤테로환 활성제의 저장 제형
WO2007073398A2 (en) * 2005-05-23 2007-06-28 Natural Alternatives International Compositions and methods for the sustained release of beta-alanine
US20070202186A1 (en) 2006-02-22 2007-08-30 Iscience Interventional Corporation Apparatus and formulations for suprachoroidal drug delivery
JP5107585B2 (ja) * 2007-01-29 2012-12-26 株式会社 メドレックス 低温充填ゼリー組成物とその製造方法
EP1985286A1 (en) * 2007-04-24 2008-10-29 Biocompatibles UK Limited Microspheres for treatment of brain tumours
BR112013009205A2 (pt) 2010-10-15 2016-07-26 Iscience Interventional Corp dispositivo para colocação na esclera de um olho, método para acessar o espaço supracoroidal de um olho, para acessar o espaço subretinal de um olho e para colocar um orifício dentro de um trato escleral em um olho.
SG10201702674PA (en) 2013-05-03 2017-06-29 Clearside Biomedical Inc Apparatus and methods for ocular injection
US10010447B2 (en) 2013-12-18 2018-07-03 Novartis Ag Systems and methods for subretinal delivery of therapeutic agents
RU2710491C2 (ru) 2014-06-20 2019-12-26 Клиасайд Байомедикал, Инк. Устройство для инъекции лекарственного средства в глазную ткань и способ инъекции лекарственного средства в глазную ткань
EP3413851B1 (en) 2016-02-10 2023-09-27 Clearside Biomedical, Inc. Packaging
JP2019514581A (ja) 2016-05-02 2019-06-06 クリアサイド バイオメディカル,インコーポレイテッド 眼の薬物送達のためのシステムおよび方法
IL264764B2 (en) 2016-08-12 2024-02-01 Clearside Biomedical Inc Devices and methods for adjusting the insertion depth of a drug administration needle
WO2018204515A1 (en) 2017-05-02 2018-11-08 Georgia Tech Research Corporation Targeted drug delivery methods using a microneedle
IL278899B2 (en) * 2018-06-04 2024-03-01 Spermvital As A useful kit for preparing hydrogels
CN112969479A (zh) * 2018-11-06 2021-06-15 国立癌症中心 海藻酸基注射型凝胶体系
CN113423386A (zh) * 2019-10-01 2021-09-21 美国倍利年制药有限公司 治疗或预防肥胖和体重管理的方法
US20230105586A1 (en) * 2020-03-26 2023-04-06 Osaka University Supporting bath for three-dimensional (3d) tissue culture
CN114533653B (zh) * 2020-11-26 2023-12-22 上海凯茂生物医药有限公司 一种人促红素杂合Fc融合蛋白相变型制剂及其制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5416979B2 (enExample) * 1972-01-08 1979-06-26
US4241099A (en) * 1979-02-26 1980-12-23 Tiemstra Peter J Pectin formulations, products and methods having delayed-action acidulants
US4789516A (en) * 1983-04-15 1988-12-06 Damon Biotech, Inc Production of sustained released system
US4690682A (en) * 1983-04-15 1987-09-01 Damon Biotech, Inc. Sustained release
US4744933A (en) * 1984-02-15 1988-05-17 Massachusetts Institute Of Technology Process for encapsulation and encapsulated active material system
CA1215922A (en) * 1984-05-25 1986-12-30 Connaught Laboratories Limited Microencapsulation of living tissue and cells
JPS645460A (en) * 1987-06-29 1989-01-10 Sanei Kagaku Kogyo Kk Production of delaying gelatinous material
JPH0794583B2 (ja) * 1989-12-15 1995-10-11 株式会社大塚製薬工場 高含水高分子ゲル
IT1245383B (it) * 1991-03-28 1994-09-20 Eniricerche Spa Composizione acquosa gelificabile avente tempo di gelificazione ritardato
US5711968A (en) * 1994-07-25 1998-01-27 Alkermes Controlled Therapeutics, Inc. Composition and method for the controlled release of metal cation-stabilized interferon
KR960006730B1 (ko) * 1993-02-11 1996-05-23 재단법인한국화학연구소 에멀젼 네트웍(emulsion network)을 이용한 약물의 피부 전달체계
GB9708773D0 (en) * 1997-04-30 1997-06-25 Reckitt & Colmann Prod Ltd Organic compositions

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9572800B2 (en) 2012-11-08 2017-02-21 Clearside Biomedical, Inc. Methods and devices for the treatment of ocular diseases in human subjects

Similar Documents

Publication Publication Date Title
JP2000509912A5 (enExample)
JP2000510751A5 (enExample)
JP2001510627A5 (enExample)
JP2002507280A5 (enExample)
JP2000509942A5 (enExample)
JP2000509635A5 (enExample)
JP2000509637A5 (enExample)
JP2001516277A5 (enExample)
JP2002513359A5 (enExample)
JP2000509587A5 (enExample)
JP2000510793A5 (enExample)
JP2000508022A5 (enExample)
JP2000508841A5 (enExample)
JP2002504013A5 (enExample)
JP2000508680A5 (enExample)
JP2000509804A5 (enExample)
JP2000509853A5 (enExample)
JP2000509755A5 (enExample)
JP2001525826A5 (enExample)
JP2000510247A5 (enExample)
JP2000510969A5 (enExample)
JP2000508102A5 (enExample)
JP2000508836A5 (enExample)
JP2000509520A5 (enExample)
JP2000509818A5 (enExample)